Mark Lin is a Irvine, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Mark Lin is A164754 for Ophthalmology in California. Mark Lin is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Mark Lin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
17582 Manchester Ave, Irvine, California, 92614-6646
Phone:
949-350-5582
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1760984470
NPI Enumeration Date:
08 Mar, 2018
NPI Last Update On:
04 Mar, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mark Lin are as mentioned below.
License Number
Specialization
State
Status
A164754
Ophthalmology
California
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
17582 Manchester Ave, Irvine, California
Zip:
92614-6646
Phone Number:
949-350-5582
Fax Number:
--
Patients can reach Mark Lin at 17582 Manchester Ave, Irvine, California or can call to book an appointment on 949-350-5582. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.